Download full report with analyst certification and important disclosures
Dec 11 2020, 06:30 GMT
DSM's recent Investor Event confirmed management's ambition in the Nutrition arena, with equal emphasis placed on the Human and Animal Nutrition (AN) growth platforms. The elevation of a solutions-focused offering is notable â the concept of end-to-end personalised or 'precision' nutrition now forms a key pillar of DSM's innovation agenda. Following our deep-dive report on DSM's AN business, we maintain strong conviction on model relevancy and structural growth with enhanced financial firepower. We reiterate our 'Outperform' rating.